GraniteShares Advisors’s AbbVie ABBV Stock Holding History

GraniteShares Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,107	Closed	-$688K	–	91
2023 Q2	$688K	Sell	5,107 -187	-4%	-$27.4K	0.62%	57
2023 Q1	$844K	Sell	5,294 -115	-2%	-$17.6K	0.75%	55
2022 Q4	$874K	Sell	5,409 -1,039	-16%	-$159K	0.72%	34
2022 Q3	$865K	Sell	6,448 -733	-10%	-$105K	0.7%	36
2022 Q2	$1.1M	Sell	7,181 -732	-9%	-$112K	0.81%	31
2022 Q1	$1.28M	Sell	7,913 -757	-9%	-$110K	0.7%	29
2021 Q4	$1.17M	Buy	+8,670	New	+$1.02M	0.54%	41

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GraniteShares Advisors's ABBV Position: Q3 2023 in Review

GraniteShares Advisors sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 5,107 shares — an estimated $688K sold.

GraniteShares Advisors first reported a position in ABBV in Q4 2021 and held it in 7 quarters. The position peaked at $1.28M in Q1 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

GraniteShares Advisors reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
GraniteShares Advisors sold 5,107 AbbVie shares in Q3 2023, an estimated $688K.
GraniteShares Advisors first reported a position in AbbVie in Q4 2021 and held it in 7 quarters.
GraniteShares Advisors's AbbVie position peaked at $1.28M in Q1 2022.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on GraniteShares Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.